News

Mauna Kea Technologies Announces 9 Presentations Demonstrating the Clinical Value of Cellvizio® at Digestive Disease Week® 2024

6 May 2024

AI, pancreatic cancer and food intolerance headline wide range of Cellvizio abstracts at gastroenterology’s largest international meeting 

Paris and Boston, May 6, 2024 – 5:45 p.m. CEST – Mauna Kea Technologies (Euronext Growth: ALMKT), inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy (p/nCLE) platform, today announced the presentation of 9 abstracts supporting Cellvizio® at the Digestive Disease Week® (DDW) Conference, being held on May 18-21, 2024 in Washington, DC. These abstracts focus on artificial intelligence, pancreatic cystic lesions and pancreatic cancer, food intolerance and other gastrointestinal disorders. Studies and presentations are focused on how the use of Cellvizio® positively impacts patient management and outcomes. 

Members of the Mauna Kea executive team will be present at DDW and meeting with physicians, industry partners, and societies, and welcome the opportunity to discuss the Company’s recent achievements and future opportunities as announced in the recent FY 2023 & Q1 2024 sales press release. 

"Each year, DDW brings the entire gastroenterology healthcare community together, and we are proud to have such a wide range of independent scientific abstracts and data about Cellvizio on display, especially in the rapidly developing field of artificial intelligence,” said Sacha Loiseau, Ph.D., Chairman and Chief Executive Officer of Mauna Kea Technologies. “Cellvizio's role in the classification and risk stratification of pancreatic cysts advances the outlook for the management of patients at risk of pancreatic cancer. Moreover, our clinical value in food intolerance identification and management is maturing quickly, setting up the next big opportunity for Cellvizio.” 

Highlighted featured presentations: 

ARTIFICIAL INTELLIGENCE-ASSISTED AUTOMATED PREDICTION OF ADVANCED NEOPLASIA IN IPMNS: A FUNCTIONAL MODEL 
Sunday, May 19, 10:32am-10:39am 
Session 3290 
Presenting author: Dr. Erica Park, The Ohio State University Wexner Medical Center 
 
CONFOCAL LASER ENDOMICROSCOPY WITH FOOD ALLERGY SENSITIVITY TESTING TO DETECT ATYPICAL FOOD ALLERGIES IN PEDIATRIC PATIENTS WITH CHRONIC ABDOMINAL PAIN AND IRRITABLE BOWEL SYNDROME 
Tuesday, May 21, 8:11am-8:18am 
Session 5145 
Presenting author: Dr. Clifton Huang, Cook Children’s Health Care System 
 
ACCURACY OF REAL-TIME EUS-GUIDED CONFOCAL LASER ENDOMICROSCOPY INTERPRETATION FOR DISCERNING SPECIFIC TYPES OF PANCREATIC CYSTIC LESIONS: INSIGHTS FROM A MULTICENTER PROSPECTIVE STUDY 
Tuesday, May 21, 10:15am-10:30am 
Session 5260 
Presenting author: Dr. Jordan Burlen, The Ohio State University Wexner Medical Center 
 
Featured poster sessions: 
 
THE ROLE OF CONFOCAL ENDOMICROSCOPY FOR THE DIAGNOSIS OF GASTRIC ANTRAL VASCULAR ECTASIA 
Saturday, May 18, 12:30pm-1:30pm 
Session 6325 
Presenting author: Dr. Navkiran Randhawa, Franciscan Health 
 
IMPROVING PRE-SURGICAL RISK STRATIFICATION THROUGH EUS-CONFOCAL ENDOMICROSCOPY: INSIGHTS FROM AN INTEROBSERVER AGREEMENT STUDY AMONG PANCREATICOBILIARY PATHOLOGISTS IN THE CLASSIFICATION OF DYSPLASIA FOR IPMNS 
Monday, May 20, 12:30pm-1:30pm 
Session 8165 
Presenting author: Dr. Matthew Leupold, The Ohio State University Wexner Medical Center 
 
COMPARISON OF DIAGNOSTIC ACCURACY OF ENDOCYTOSCOPY AND PROBE-BASED CONFOCAL LASER ENDOMICROSCOPY 
Monday, May 20, 12:30pm-1:30pm 
Session 8390 
Presenting author: Dr. Ah Young Lee, CHA Gangnam Medical Center 
 
PRE-OPERATIVE RISK STRATIFICATION OF IPMNS USING FUKUOKA GUIDELINES AND CONFOCAL ENDOMICROSCOPY IMAGING 
Monday, May 21, 12:30pm-1:30pm 
Session 9255 
Presenting author: Dr. Matthew Leupold, The Ohio State University Wexner Medical Center 
 
ASSOCIATIONS BETWEEN PREOPERATIVE ENDOSCOPIC ULTRASOUND-GUIDED CONFOCAL LASER ENDOMICROSCOPY (EUS-CLE) AND HISTOLOGICAL SUBTYPE OF INTRADUCTAL PAPILLARY MUCINOUS NEOPLASMS (IPMN) 
Monday, May 21, 12:30pm-1:30pm 
Session 9240 
Presenting author: Dr. Bryn Koehler, The Ohio State University Wexner Medical Center 
 
FOOD-INDUCED INTESTINAL MUCOSAL REACTIONS IN IRRITABLE BOWEL SYNDROME DETECTED WITH CONFOCAL LASER ENDOMICROSCOPY 
Monday, May 21, 12:30pm-1:30pm 
Session 9345 
Presenting author: Dr. Amanda Blomsten, University of Gothenburg 

Latest News

Mauna Kea Technologies Provides an Update on Its Recent Developments

Mauna Kea Technologies Provides an Update on Its Recent Developments

Mauna Kea Technologies Announces New Positive Clinical Results for Cellvizio in Food Intolerance

Mauna Kea Technologies Announces New Positive Clinical Results for Cellvizio in Food Intolerance

Mauna Kea Technologies Reports H1 2024 Financial Results and Q3 2024 Sales

Mauna Kea Technologies Reports H1 2024 Financial Results and Q3 2024 Sales